For all men, the rate jumped from 2.1 deaths per 100,000 people in 1999 to 7.2 in 2020 – a 243% increase. For men ages 55 to 64, the rate increased 165%, from 5.5 deaths per 100,000 people in 1999 to ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Biohaven's pipeline includes Troriluzole for SCA, BHV-2100 for migraines, and Taldefgrobep Alfa for SMA. See why BHVN stock ...

Netherlands: A recent study, published in Diabetes, Obesity and Metabolism has revealed that atrasentan, an endothelin ...

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

Beijing has launched a three-year plan to tackle obesity, with rates of overweight children and adults rapidly increasing in ...

New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

In today’s fast-paced world, many of us find ourselves glued to our chairs for hours on end - whether it’s at the office, ...

New research reveals that popular diabetes and weight-loss drugs may also protect the kidneys. This groundbreaking study, ...

Fatty liver disease is a growing health concern that often develops silently, showing no clear symptoms in its early stages.

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.